Novel Multiparallel Initiative For The Discovery of Antibiotics, Anti-Cancer Drugs And Immunomodulatory Compounds

• Unité de recherche: INNOSUISSE
• Numéro de projet: 6953.1;9 BTS-LS
• Titre du projet anglais: Novel Multiparallel Initiative For The Discovery of Antibiotics, Anti-Cancer Drugs And Immunomodulatory Compounds

Description succincte (Anglais)

Novel Multiparallel Initiative For The Discovery of Antibiotics, Anti-Cancer Drugs And Immunomodulatory Compounds

Résumé des résultats (Abstract) (Anglais)

This project will provide novel assays for the discovery of drugs active against predominant diseases in industrialized countries. Discovery initiative will focus on novel antibiotics, anti-cancer drugs and immunomodulatory compounds. Merging the award-winning drug-specific biosensor technology of Cistronics Anti-infectives AG (bundling the CTI-certified anti-infectives activities This project will provide novel assays for the discovery of drugs active against predominant diseases in industrialized countries. Discovery initiative will focus on novel antibiotics, anti-cancer drugs and immunomodulatory compounds. Merging the award-winning drug-specific biosensor technology of Cistronics Anti-infectives AG (bundling the CTI-certified anti-infectives activities of Cistronics Cell Technology GmbH) with the conditional molecular intervention portfolio of the ETHZ molecular biotechnology group will provide a unique opportunity for a high-leverage drug discovery initiative. Capitalizing on Cistronics¿ proprietary biosensors, proteins which recognize chemical c